ArticleRSC advances2023
Facile fabrication of plasmonic Ag/ZIF-8: an efficient catalyst for investigation of antibacterial, haemolytic and photocatalytic degradation of antibiotics.
Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Visible light active BiBMC chemistry · 2026Article
- Cu-Cy Nps@ZIF-8@HA-Mediated Photodynamic Therapy for Cutaneous Squamous Cell Carcinoma.International journal of nanomedicine · 2026Article
- Rapid synthesis of phosphomolybdic acid encapsulated ZIF-8 for efficient uranium(vi) capture from alkaline solution.RSC advances · 2025Article
- Facile synthesis of ZIF-8@GO composites for enhanced adsorption of cationic and anionic dyes from their aqueous solutions.RSC advances · 2025Article
- Stabilization of Ni-containing Keggin-type polyoxometalates with variable oxidation states as novel catalysts for electrochemical water oxidation.Chemical science · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Present article represents the fabrication of plasmonic Ag/ZIF-8 composite and its effect on antibacterial, haemolytic and photocatalytic degradation of antibiotics. Ag/ZIF-8 was prepared by varying molar concentrations (1 mM, 2.5 mM, and 5 mM) of AgNO
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.